Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 17 Aug 2026 for Avalo Therapeutics, Inc., €85k.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Mittie Doyle: trading record in brief
This profile gathers the share dealings of Mittie Doyle in Avalo Therapeutics, Inc. In total, 2 filings cover trades dated from 10 August 2026 to 17 August 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Most recently, on 17 August 2026, the filings show a transaction worth €85k in Avalo Therapeutics, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Mittie Doyle
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
5,037 shares@ US$19.59CommonSEC144:0001950047-26-008276
679 shares@ US$18.320.0012% mcap100.0% of flowCommonSEC144:0001950047-26-007908
2 of 2 declarations
